Stockreport

AnaptysBio Stock Down as Eczema Study Fails to Meet Goals [Yahoo! Finance]

AnaptysBio, Inc.  (ANAB) 
Last anaptysbio, inc. earnings: 3/2 08:45 am Check Earnings Report
US:NASDAQ Investor Relations: ir.anaptysbio.com/investor-relations
PDF Consequently, ANAB discontinued any further investment in this asset. AnaptysBio has lost 27.6% so far this year compared with the industry's decline of 8.1%. Image [Read more]